Hypericum triquetrifolium Turra. extract exhibits antinociceptive activity in the mouse

Journal of Ethnopharmacology

Volumn 67, Issue 3, 1999, Pages 307-312

  Apaydin, Sebnem ^a   Zeybek, Ulvi ^a   Ince, Iskender ^a   Elgin, Gozde ^a   Karamenderes, Canan ^a   Ozturk, Bintug ^a   Tuglular, Isik ^a  

^a EGE UNIVERSITY   (Turkey)

Author keywords

Antinociceptive effect; Hypericum triquetrifolium; Mouse

Indexed keywords

HYPERICUM EXTRACT; HYPERICUM TRIQUETRIFOLIUM EXTRACT; UNCLASSIFIED DRUG;

ANTIINFLAMMATORY ACTIVITY; ANTINOCICEPTION; ARTICLE; DRUG ACTIVITY; DRUG MECHANISM; ETHNOPHARMACOLOGY; MALE; MOUSE; NONHUMAN; PERFORMANCE; SENSORIMOTOR FUNCTION; SEROTONIN UPTAKE; TAIL FLICK TEST;

ANALGESICS; ANIMALS; HYPERICUM; MALE; MICE; PLANT EXTRACTS; PLANTS, MEDICINAL;

EID: 0032886871     PISSN: 03788741     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0378-8741(99)00071-9     Document Type: Article

References (37)

1. Bamigbade, T.A., Davidson, C., Langford, R.M., Stamford, J., 1997. Actions of tramadol, its enantiomers and principal metabolite, O -desmethyltramadol, on serotonin (5-HT) efflux and uptake in the rat dorsal raphe nucleus. Br. J. Anaesth. 79, 352-356.
2. Baytop, T., 1984. Therapy with Medicinal Plants in Turkey. Publications of Istanbul University, Istanbul, pp. 185-186.
3. Bendtsen, L., Jensen, R., Olesen, J., 1996. A non-selective (amitriptyline), but not a selective (citalopram), serotonin reuptake inhibitor is effective in the prophylactic treatment of chronic tension-type headache. J. Neurol. Neurosurg. Psychiatr. 61, 285-290.
4. Bladt, S., Wagner, H., 1994. Inhibition of MAO by fractions and constituents of hypericum extract. J. Geriatr. Psychiatr. Neurol. 7 (Suppl 1), 57-59.
5. 1 receptor antagonists: non-specific effects of racemic RP67580. Br. J. Pharmacol. 113, 1372-1376.
6. Cott, J., 1995. Medical plants and dietary supplements: Sources for innovative treatments or adjusts? Psychopharmacol. Bull. 31, 131-137.
7. Demisch, L., Hölzl, B., Gollnik, B., Kaczmarczyk, P., 1989. Identification of selective MAO-Type-A inhibitors in Hypericum perforatum L. (Hyperforat®). Pharmacopsychiatry 22, 194.
8. Dubuisson, D., Dennis, S.G., 1977. The formalin test: a quantitative study of the analgesic effects of morphine, meperidine and brain stem stimulation in rats and cats. Pain 4, 161-174.
9. Ernst, E., 1995. St. John's wort, an antidepressant? A systematic, criteria based review. Phytomedicine 2, 67-71.
10. Fasmer, O.B., Hunskaar, S., Hole, K., 1989. Antinociceptive effects of serotonergic reuptake inhibitors in mice. Neuropharmacology 28, 1363-1366.
11. Gatch, M.B., Negus, S.S., Mello, N.K., 1998. Antinociceptive effects of monoamine reuptake inhibitors administered alone or in combination with mu opioid agonists in rhesus monkeys. Psychopharmacology 135, 99-106.
12. Handy, R.L.C., Wallace, P., Gaffen, Z.A., Whitehead, K.J., Moore, P.K., 1995. The antinociceptive effect of 1-(2-trifluoromethylphenyl) imidazole (TRIM), a potent inhibitor of neuronal nitric oxide synthase in vitro, in the mouse. Br. J. Pharmacol. 116, 2349-2350.
13. Harrer, G., Schulz, V., 1994. Clinical investigation of tha antidepressant effectiveness of hypericum. J. Geriatr. Psychiatr. Neurol. 7 (Suppl 1), 6-8.
14. Heapy, C.G., Jamieson, A., Russell, N.J.W., 1987. Afferent C-fibre and A-delta activity in models of inflammation. Br. J. Pharmacol. 90, 164.
15. Hölzl, J., 1993. Inhaltsstoffe und Wirkmechanismen des Johanniskrautes. Zeitschrift für Phytotherapie 14, 255-264.
16. Hunskaar, S., Fasmer, O.B., Hole, K., 1985. Formalin test in mice, a useful technique for evaluating mild analgesics. J. Neurosci. Methods 14, 69-76.
17. Hunskaar, S., Hole, K., 1987. The formalin test in mice: dissociation between inflammatory and non-inflammatory pain. Pain 30, 103-114.
18. Linde, K., Ramirez, G., Mulrow, C.D., Pauls, A., Weidenhammer, W., Melchart, D., 1996. St John's wort for depression-an overview and meta-analysis of randomized clinical trials. Br. Med. J. 313, 253-258.
19. G-nitro arginine methyl ester exhibits antinociceptive activity in the mouse. Br. J. Pharmacol. 102, 198-202.
20. Müller, W.E., Rolli, M., Schafer, C., Hafner, U., 1997. Effects of hypericum extract (LI 160) in biochemical models of antidepressant activity. Pharmacopsychiatry 30 (Suppl 2), 102-107.
21. Perovic, S., Müller, W.E., 1995. Pharmacological profile of Hypericum extract. Effect on serotonin uptake by postsynaptic receptors. Arzneimittelforschung 45 (11), 1145-1148.
22. Reuter, H.D., 1993. Hypericum als pflanzliches Antidepressivum. Zeitschrift für Phytotherapie 14, 239-254.
23. Rolli, M., Schafer, C., Müller, W.E., 1995. Effect of hypericum extract (LI 160) on neurotransmitter receptor binding and synaptosomal uptake systems. Pharmacopsychiatry 28, 207.
24. Rupniak, N.M.J., Boyce, S., Williams, A.R., Cook, G., Long-more, J., Seabrook, G.R., Caeser, M., Iversen, S.D., Hill, R.G., 1993. Br. J. Pharmacol. 110, 1607-1613.
25. Shipochliev, T., Dimitrov, A., Aleksandrova, E., 1981. Antiinflammatory action of a group of plant extracts. Vet. Med. Nauki 18, 87-94.
26. Sparenberg, B., Demisch, L., Hölzl, J., 1993. Untersuchungen über antidepressive Wirkstoffe von Johanniskraut. Pharm. Zeitung Wissung 138, 50-54.
27. Stamford, J.A., 1995. Descending control of pain. Br. J. Anaesth. 75, 212-227.
28. Suzuki, O., Katsumata, Y., Oya, M., 1978. Inhibition of monoamine oxidase by isogentisin and its 3-O-Glucoside. Biochem. Pharmacol. 27, 2075-2078.
29. Suzuki, O., Katsumata, Y., Chari, M., 1981. Inhibition of type A and type B monoamine oxidase by naturally occuring xanthonea. Planta Med. 50, 272-274.
30. 2A receptors. Pharmacopsychiatry 30 (Suppl 2), 113-116.
31. Tjolsen, A., Berge, O., Hunskaar, S., Rosland, J.H., Hole, K., 1992. The formalin test: an evaluation of the method. Pain 51, 5-17.
32. Tura, B., Tura, S.M., 1990. The analgesic effect of tricyclic antidepressants. Brain Res. 518, 19-22.
33. Volz, H.P., 1997. Controlled clinical trials of hypericum extracts in depressed patients - an overview. Pharmacopsychiatry 30 (Suppl 2), 72-76.
34. Vorbach, E.U., Arnoldt, K.H., Hubner, W.D., 1997. Efficacy and tolerability of St.John's wort extract LI 160 versus imipramine in patients with severe depressive episodes according to ICD-10. Pharmacopsychiatry 30 (Suppl 2), 81-85.
35. Wagner, I., Bladt, S., 1994. Pharmacetical quality of Hypericum extracts. J. Geriatr. Psychiatr. Neurol. 7 (Suppl 1), 65-68.
36. Wheatly, D., 1997. LI 160, an extract of St. John's wort, versus amitriptyline in mildly to moderately depressed outpatients - a controlled 6-week clinical trial. Pharmacopsychiatry 30 (Suppl 2), 77-80.
37. Zimmermann, M., 1983. Ethical guidelines for investigations of experimental pain in conscious animals. Pain 16, 109-110.